Literature DB >> 8607766

Measuring self-efficacy in people with multiple sclerosis: a validation study.

C E Schwartz1, L Coulthard-Morris, Q Zeng, P Retzlaff.   

Abstract

OBJECTIVE: To assess the psychometric properties of a measure of self-efficacy in people with multiple sclerosis (MS).
DESIGN: Cross-sectional study by mail with retest.
SETTING: MS Clinic registry of a large Boston teaching hospital . PATIENTS: 141 MS patients representing a broad range of disability. MAIN OUTCOME MEASURES: The MS Self-Efficacy Scale (MSSE), the Expanded Disability Status Scale, the Sickness Impact Profile, and the mastery subscale of the Ryff Happiness Scale.
RESULTS: The MSSE has high internal consistency and test-retest reliability, both for the overall scale and for the SE Function and SE Control subscales. Results of convergent and divergent validity analyses suggest that the scale is both sensitive and specific.
CONCLUSIONS: We conclude that MSSE is appropriate for assessing self-efficacy in the MS population.

Entities:  

Mesh:

Year:  1996        PMID: 8607766     DOI: 10.1016/s0003-9993(96)90091-x

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  38 in total

1.  Physical activity, self-efficacy, and health-related quality of life in persons with multiple sclerosis: analysis of associations between individual-level changes over one year.

Authors:  Robert W Motl; Edward McAuley; Daniel Wynn; Brian Sandroff; Yoojin Suh
Journal:  Qual Life Res       Date:  2012-03-09       Impact factor: 4.147

2.  A multicenter study of the predictors of adherence to self-injected glatiramer acetate for treatment of relapsing-remitting multiple sclerosis.

Authors:  Howard Zwibel; Gabriel Pardo; Shelly Smith; Douglas Denney; Merrikay Oleen-Burkey
Journal:  J Neurol       Date:  2010-10-06       Impact factor: 4.849

3.  A randomized controlled trial of a cognitive rehabilitation intervention for persons with multiple sclerosis.

Authors:  Alexa K Stuifbergen; Heather Becker; Frank Perez; Janet Morison; Vicki Kullberg; Ana Todd
Journal:  Clin Rehabil       Date:  2012-02-02       Impact factor: 3.477

Review 4.  Compliance, adherence, and the treatment of multiple sclerosis.

Authors:  Thomas Klauer; Uwe K Zettl
Journal:  J Neurol       Date:  2008-12       Impact factor: 4.849

Review 5.  Quality of life in multiple sclerosis: determinants, measurement, and use in clinical practice.

Authors:  Deborah M Miller; Rebecca Allen
Journal:  Curr Neurol Neurosci Rep       Date:  2010-09       Impact factor: 5.081

6.  Validation of the Social Provisions Scale in people with multiple sclerosis.

Authors:  Chung-Yi Chiu; Robert W Motl; Nicole Ditchman
Journal:  Rehabil Psychol       Date:  2016-04-18

7.  Self-efficacy as a predictor of self-reported physical, cognitive, and social functioning in multiple sclerosis.

Authors:  Margaret M Schmitt; Yael Goverover; John Deluca; Nancy Chiaravalloti
Journal:  Rehabil Psychol       Date:  2013-12-09

8.  Multi-centre parallel arm randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based cognitive behavioural approach to managing fatigue in people with multiple sclerosis.

Authors:  Peter W Thomas; Sarah Thomas; Paula Kersten; Rosemary Jones; Alison Nock; Vicky Slingsby; Colin Green; Roger Baker; Kate Galvin; Charles Hillier
Journal:  BMC Neurol       Date:  2010-06-16       Impact factor: 2.474

Review 9.  Health-related quality of life in multiple sclerosis: current evidence, measurement and effects of disease severity and treatment.

Authors:  Richard A Rudick; Deborah M Miller
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

10.  Physical activity and quality of life in multiple sclerosis: intermediary roles of disability, fatigue, mood, pain, self-efficacy and social support.

Authors:  Robert W Motl; Edward McAuley; Erin M Snook; Rachael C Gliottoni
Journal:  Psychol Health Med       Date:  2009-01       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.